Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218484 · ClinicalTrials.gov registry record · NA

VoiceLove Digital Therapy for Delirium in the ICU

A NA study of Delirium, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07218484 is a NA study of Delirium that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 15 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07218484, a NA study of Delirium, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The study is a single-center, single-arm, prospective trial to evaluate the feasibility, safety, and acceptability of VoiceLOVE digital therapy for the management of delirium in surgical ICU patients. 15 participants will be enrolled. The study expects that 70% of participants will complete 20 -25 minutes of the VoiceLOVE digital therapy. Descriptive statistics will be used to summarize the findings. The intent is that this study will provide information for a larger, subsequent clinical trial of surgical ICU patients who are at risk for delirium.

Conditions Studied

Interventions

  • BEHAVIORAL VoiceLove therapy

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-08-21
Est. Completion 2026-01-31
Phase NA

What the Registry Record Tells You About NCT07218484

The ClinicalTrials.gov registry entry for NCT07218484 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (98% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which VoiceLove therapy is the first listed.

NCT07218484 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07218484 about?

NCT07218484 is a clinical study titled "VoiceLove Digital Therapy for Delirium in the ICU". The study is a single-center, single-arm, prospective trial to evaluate the feasibility, safety, and acceptability of VoiceLOVE digital therapy for the management of delirium in surgical ICU patients. 15 participants will be enrolled. The study expects that 70% of participants will complete 20 -25 m...

What is the current status of trial NCT07218484?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-08-21. Estimated completion is 2026-01-31.

What conditions does trial NCT07218484 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT07218484?

The interventions under investigation include: VoiceLove therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07218484?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218484 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.